.png)
Report Library
View More
Datamonitor Healthcare I&I Disease ...
May 28, 2021
Datamonitor Healthcare Oncology Dis...
May 26, 2021
Datamonitor Healthcare Oncology Dis...
May 26, 2021
Datamonitor Healthcare Infectious D...
May 25, 2021
Datamonitor Healthcare I&I: Dry Eye...
May 24, 2021
Datamonitor Healthcare I&I: Systemi...
May 21, 2021
Datamonitor Healthcare Urology: Ove...
May 21, 2021
Datamonitor Healthcare Oncology Dis...
May 20, 2021
Datamonitor Healthcare Oncology: Ho...
May 20, 2021
Datamonitor Healthcare Oncology: Ne...
May 20, 2021
Impact Events
More| Date | Lead Company |
Event | Type | Approval Change |
Approval Likelihood |
|---|---|---|---|---|---|
| 5/27/21 | Provention Bio (PRVB) | Teplizumab for Diabetes Mellitus, Type I | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/26/21 | Pacira BioSciences (PCRX) | Exparel for Postsurgical Pain | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/25/21 | AB Science (AB) | Masitinib for Prostate Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/25/21 | Oncopeptides AB (ONCO) | Pepaxto for Multiple Myeloma (MM) | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/25/21 | Provention Bio (PRVB) | Teplizumab for Diabetes Mellitus, Type I | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range |
Lead Company |
Drug | Expected Catalyst |
|---|---|---|---|
| 08/16/19 | Subscribers Only | Subscribers Only | Partnership - Acquisition Completion |
| 05/28/21 | Subscribers Only | Subscribers Only | Regulatory - PDUFA/Approval Decision (US) |
| 05/30/21 | Subscribers Only | Subscribers Only | Trial Data - Top-Line Results |
| 05/30/21 | Subscribers Only | Subscribers Only | Regulatory - CHMP (European Panel) Results |
| 05/30/21 | Subscribers Only | Subscribers Only | Regulatory - CHMP (European Panel) Results |
